412 related articles for article (PubMed ID: 28743274)
21. Use of lymphoscintigraphy to differentiate primary versus secondary lower extremity lymphedema after surgical lymphadenectomy: a retrospective analysis.
Roman MM; Barbieux R; Nogaret JM; Bourgeois P
World J Surg Oncol; 2018 Apr; 16(1):75. PubMed ID: 29631609
[TBL] [Abstract][Full Text] [Related]
22. Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging.
Menderes G; Azodi M; Schwartz P; Silasi DA
Int J Gynecol Cancer; 2015 Jan; 25(1):160-5. PubMed ID: 25386859
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for lower-limb lymphedema after surgery for cervical cancer.
Ohba Y; Todo Y; Kobayashi N; Kaneuchi M; Watari H; Takeda M; Sudo S; Kudo M; Kato H; Sakuragi N
Int J Clin Oncol; 2011 Jun; 16(3):238-43. PubMed ID: 21213009
[TBL] [Abstract][Full Text] [Related]
24. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors.
Hayes SC; Janda M; Ward LC; Reul-Hirche H; Steele ML; Carter J; Quinn M; Cornish B; Obermair A
Gynecol Oncol; 2017 Sep; 146(3):623-629. PubMed ID: 28624154
[TBL] [Abstract][Full Text] [Related]
25. Validation of a breast cancer nomogram to predict lymphedema in a Chinese population.
Li X; Huang H; Lin Q; Yu Q; Zhou Y; Long W; Wang N
J Surg Res; 2017 Apr; 210():132-138. PubMed ID: 28457319
[TBL] [Abstract][Full Text] [Related]
26. GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients.
Carlson JW; Kauderer J; Hutson A; Carter J; Armer J; Lockwood S; Nolte S; Stewart BR; Wenzel L; Walker J; Fleury A; Bonebrake A; Soper J; Mathews C; Zivanovic O; Richards WE; Tan A; Alberts DS; Barakat RR
Gynecol Oncol; 2020 Feb; 156(2):467-474. PubMed ID: 31837831
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy.
Todo Y; Yamamoto R; Minobe S; Suzuki Y; Takeshi U; Nakatani M; Aoyagi Y; Ohba Y; Okamoto K; Kato H
Gynecol Oncol; 2010 Oct; 119(1):60-4. PubMed ID: 20638109
[TBL] [Abstract][Full Text] [Related]
28. Reduction/prevention of lower extremity lymphedema after pelvic and para-aortic lymphadenectomy for patients with gynecologic malignancies.
Hareyama H; Ito K; Hada K; Uchida A; Hayakashi Y; Hirayama E; Oikawa M; Okuyama K
Ann Surg Oncol; 2012 Jan; 19(1):268-73. PubMed ID: 21717243
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of response to CDP in lower limb lymphedema (LLL) after pelvic cancer treatment.
Liao SF; Li SH; Huang HY
Gynecol Oncol; 2012 Jun; 125(3):712-5. PubMed ID: 22426250
[TBL] [Abstract][Full Text] [Related]
30. Evidence-based practice in the management of lower limb lymphedema after gynecological cancer.
Iwersen LF; Sperandio FF; Toriy AM; Palú M; Medeiros da Luz C
Physiother Theory Pract; 2017 Jan; 33(1):1-8. PubMed ID: 27918865
[TBL] [Abstract][Full Text] [Related]
31. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up.
Ribeiro Pereira ACP; Koifman RJ; Bergmann A
Breast; 2017 Dec; 36():67-73. PubMed ID: 28992556
[TBL] [Abstract][Full Text] [Related]
32. The Association Between the Number of Retrieved Pelvic Lymph Nodes and Ipsilateral Lower Limb Lymphedema in Patients With Gynecologic Cancer.
Jung SG; Im SH; Kim M; Choi MC; Joo WD; Song SH; Lee C; Park H
J Invest Surg; 2022 May; 35(5):978-983. PubMed ID: 34545757
[TBL] [Abstract][Full Text] [Related]
33. Incidence of lower limb lymphedema after vulvar cancer: A systematic review and meta-analysis.
Huang J; Yu N; Wang X; Long X
Medicine (Baltimore); 2017 Nov; 96(46):e8722. PubMed ID: 29145314
[TBL] [Abstract][Full Text] [Related]
34. Close relationship between removal of circumflex iliac nodes to distal external iliac nodes and postoperative lower-extremity lymphedema in uterine corpus malignant tumors.
Todo Y; Yamazaki H; Takeshita S; Ohba Y; Sudo S; Minobe S; Okamoto K; Kato H
Gynecol Oncol; 2015 Oct; 139(1):160-4. PubMed ID: 26186910
[TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors for lower limb lymphedema associated with endometrial cancer: Results from a prospective, longitudinal cohort study.
Pigott A; Obermair A; Janda M; Vagenas D; Ward LC; Reul-Hirche H; Hayes SC
Gynecol Oncol; 2020 Aug; 158(2):375-381. PubMed ID: 32499070
[TBL] [Abstract][Full Text] [Related]
36. Long term complications after radical hysterectomy with pelvic lymphadenectomy.
Manchana T; Sirisabya N; Lertkhachonsuk R; Worasethsin P; Khemapech N; Sittisomwong T; Vasuratna A; Termrungruanglert W; Tresukosol D
J Med Assoc Thai; 2009 Apr; 92(4):451-6. PubMed ID: 19374292
[TBL] [Abstract][Full Text] [Related]
37. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
38. Relationship between removal of circumflex iliac nodes distal to the external iliac nodes and postoperative lower-extremity lymphedema in uterine cervical cancer.
Yamazaki H; Todo Y; Takeshita S; Ohba Y; Sudo S; Minobe S; Okamoto K; Yamashiro K; Kato H
Gynecol Oncol; 2015 Nov; 139(2):295-9. PubMed ID: 26363210
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: A multi-institutional retrospective study.
Yoshihara M; Shimono R; Tsuru S; Kitamura K; Sakuda H; Oguchi H; Hirota A
Eur J Surg Oncol; 2020 Jul; 46(7):1334-1338. PubMed ID: 32146054
[TBL] [Abstract][Full Text] [Related]
40. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience.
Yang EJ; Ahn S; Kim EK; Kang E; Park Y; Lim JY; Kim SW
Breast Cancer Res Treat; 2016 Nov; 160(2):269-276. PubMed ID: 27665585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
